These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5800406)

  • 41. Cytosine arabinoside therapy for herpesvirus infections.
    Chow AW; Foerster J; Hryniuk W
    Antimicrob Agents Chemother (Bethesda); 1970; 10():214-7. PubMed ID: 4329712
    [No Abstract]   [Full Text] [Related]  

  • 42. [201 cases of polycythemia: results of P 32 therapy, studies on ferrokinetics (Cr 51 and Fe 59) and on erythropoietic plasma factors before, during and after treatment].
    Horst W; Rösler H; Villanueva-Meyer H
    Nucl Med (Stuttg); 1963; 2():Suppl 1:361-75. PubMed ID: 5900131
    [No Abstract]   [Full Text] [Related]  

  • 43. Low dose cytosine arabinoside in the treatment of the primary myelodysplastic syndrome.
    Pluta A; Kowalewski J; Kurowska M; Spiewak H; Hus M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):787-91. PubMed ID: 1713883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Polycythemia vera: therapeutic use of busulfan. Comparison with radioactive phosphorous].
    Jamra M; Verrastro T
    Rev Hosp Clin Fac Med Sao Paulo; 1967; 22():Suppl:241-66. PubMed ID: 5629089
    [No Abstract]   [Full Text] [Related]  

  • 45. [Preliminary results of the treatment of various forms of non-lymphoblastic leukemia with small doses of cytosine arabinoside].
    Brodzki LM; Pawelski S; Gepner-Woźniewska M
    Pol Tyg Lek; 1986 Oct; 41(43):1376-9. PubMed ID: 3469629
    [No Abstract]   [Full Text] [Related]  

  • 46. [Histologic bone marrow findings in polycythemia vera before and after P32 therapy. (At the same time a contribution to the differential diagnosis of the clinical feature "polycythemia")].
    Hauswaldt C; Hunstein W; Uhl N; Doering P
    Arch Klin Med; 1967; 213(3):219-36. PubMed ID: 5594424
    [No Abstract]   [Full Text] [Related]  

  • 47. Low dose cytosine arabinoside in adult acute non-lymphoid leukemia.
    Rossi Ferrini P; Ciolli S; Leoni F
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():36-7. PubMed ID: 2713558
    [No Abstract]   [Full Text] [Related]  

  • 48. [Results of cytosine arabinoside treatment in adult patients with acute myeloblastic leukemia].
    Gepner-Woźniewska M; Retmańska A; Sobczynska-Czechowska Z; Pawelski S
    Acta Haematol Pol; 1973; 4(1):1-9. PubMed ID: 4522083
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment of adult acute lymphoblastic leukemia with cytosine arabinoside, vincristine, and prednisone.
    Gingrich RD; Armitage JO; Burns CP
    Cancer Treat Rep; 1978 Sep; 62(9):1389-91. PubMed ID: 356988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Study of modifications of erythropoiesis in Vaquez' disease treated by radioactive phosphorus].
    Henry JA
    Acta Clin Belg; 1966; ():Suppl 2:1-97. PubMed ID: 5974089
    [No Abstract]   [Full Text] [Related]  

  • 51. [Experiences in the treatment of acute myeloblastic leukemia and acute monocytic leukemia using cytosine arabinoside and 6-thioguanine].
    Essers U; Althof S; Ewers M
    Verh Dtsch Ges Inn Med; 1975; 81():1126-8. PubMed ID: 1065154
    [No Abstract]   [Full Text] [Related]  

  • 52. Cytosine arabinoside (NSC-63878) given subcutaneously to patients with cancer.
    Savel H; Burns SL
    Cancer Chemother Rep; 1969 Apr; 53(2):153-6. PubMed ID: 5799419
    [No Abstract]   [Full Text] [Related]  

  • 53. Adverse effect of cytosine arabinoside on disseminated zoster in a controlled trial.
    Stevens DA; Jordan GW; Waddell TF; Merigan TC
    N Engl J Med; 1973 Oct; 289(17):873-8. PubMed ID: 4354007
    [No Abstract]   [Full Text] [Related]  

  • 54. [The use of cytosine arabinoside in children. III. Cytosine arabinoside in chickenpox during acute lymphoblastic leukemia].
    Masi M; Paolucci P; Vecchi V; Vivarelli F
    Minerva Pediatr; 1975 Nov; 27(34):1894-901. PubMed ID: 1064745
    [No Abstract]   [Full Text] [Related]  

  • 55. [The effect of cytosine arabinoside on cell kinetics in adult acute leukemia and its correlation to the therapeutic response].
    Furusawa S; Adachi Y; Nomura T; Komiya M
    Rinsho Ketsueki; 1972 Dec; 13(6):943-50. PubMed ID: 4675065
    [No Abstract]   [Full Text] [Related]  

  • 56. The clinical uses of cytosine arabinoside in retinoblastoma and lymphoma.
    Tungsubutra K
    J Med Assoc Thai; 1973 Sep; 56(9):514-8. PubMed ID: 4767452
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment of acute leukemia in adults with cytosine arabinoside and thioguanine].
    Kotlarek-Haus S; Lawińska B; Kuliszkiewicz-Janus M
    Acta Haematol Pol; 1978; 9(4):237-42. PubMed ID: 735711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical use of cytosine arabinoside in infancy. I. Cytosine arabinoside in the treatment of acute leukosis].
    Masi M; Vivarelli F; Paolucci P; Vecchi V
    Minerva Pediatr; 1975 Sep; 27(28):1539-50. PubMed ID: 1101022
    [No Abstract]   [Full Text] [Related]  

  • 59. Cytosine arabinoside (NSC 63878) toxicity and antitumor acitivity in human solid tumors.
    Davis HL; Rochlin DB; Weiss AJ; Wilson WL; Andrews NC; Madden R; Sedransk N
    Oncology; 1974; 29(3):190-200. PubMed ID: 4412696
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of 17 cases of non-lymphoblastic acute leukemia with a combination of daunorubicin, cytosine and arabinoside].
    Dini E; Barbui T; Cartei G; Chisesi T; Cazzavillan M; Battista R
    Minerva Med; 1975 Jul; 66(52):2619-2620. PubMed ID: 1057055
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.